Literature DB >> 144796

The close correlation between symptoms and disease expression in HLA B27 positive individuals.

A Calin, J F Fries, D Schurman, R Payne.   

Abstract

Following demonstration that 20 percent of presumed "healthy" HLA B27 positive individuals develop symptomatic ankylosing spondylitis, a controlled follow-up assessment of the remaining "asymptomatic" 80 percent was performed. The clinical and radiological study revealed that there is a close correlation between symptoms and radiologic change in HLA B27 positive subjects; those individuals remaining symptom free have normal pelvic radiographs. Ankylosing spondylitis or "asymptomatic sarcroiliitis" does not exist in a subclinical manner throughout the entire group of B27 positive subjects. Evaluation of the pelvic radiographs of both symptomatic and asymptomatic HLA B27 positive subjects and symptomatic HLA B27 negative controls demonstrated that osteitis pubis and fluffy periostitis are equally distributed among the three groups, only the frequency of sacroiliitis being statistically greater in the B27 positive symptomatic subjects.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 144796

Source DB:  PubMed          Journal:  J Rheumatol        ISSN: 0315-162X            Impact factor:   4.666


  3 in total

1.  A comparative radiological study of the pubic symphysis in rheumatic disorders.

Authors:  D L Scott; C J Eastmond; V Wright
Journal:  Ann Rheum Dis       Date:  1979-12       Impact factor: 19.103

2.  Acute anterior uveitis, ankylosing spondylitis, back pain, and HLA-B27.

Authors:  A B Beckingsale; J Davies; J M Gibson; A R Rosenthal
Journal:  Br J Ophthalmol       Date:  1984-10       Impact factor: 4.638

3.  Clinical Features and Prevalence of Spondyloarthritis in a Cohort of Italian Patients Presenting with Acute Nongranulomatous Anterior Uveitis.

Authors:  Pierluigi Macchioni; Giorgia Citriniti; Elena Bolletta; Valentina Mastrofilippo; Raffaella Aldigeri; Luca De Simone; Fabrizio Gozzi; Chantal Adani; Anna Sangiovanni; Chiara Posarelli; Michele Figus; Francesco Muratore; Nicolò Pipitone; Carlo Salvarani; Luca Cimino
Journal:  J Immunol Res       Date:  2022-01-18       Impact factor: 4.818

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.